Loss of in vitro resistance in Candida glabrata following discontinuation of fluconazole prophylaxis in a hematopoietic stem cell transplantation patient

Medical Mycology

Volumn 48, Issue 3, 2010, Pages 557-560

  Westbrook, Steven D ^a,c   Wiederhold, Nathan P ^b,d   Vallor, Ana C ^b,c   Kotara, Susann ^b   Bernardo, Stella ^b,c   Lee, Samuel A ^b,c   Kirkpatrick, William R ^b,c   Toro, Juan J ^b,c   Freytes, Cesaro ^b,c   Patterson, Thomas F ^b,c   Redding, Spencer W ^a,c  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b University of Texas Health Science Center at San Antonio   (United States)

^c SOUTH TEXAS VETERANS HEALTH CARE SYSTEM   (United States)

^d UNIVERSITY OF TEXAS AT AUSTIN   (United States)

Author keywords

Candida glabrata; Fluconazole resistance; Hematopoietic stem cell transplantation

Indexed keywords

CASPOFUNGIN; FLUCONAZOLE; MICAFUNGIN;

ADULT; ANTIBIOTIC PROPHYLAXIS; ANTIFUNGAL RESISTANCE; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; CANDIDA GLABRATA; CANDIDIASIS; CASE REPORT; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENGRAFTMENT; FUNGAL COLONIZATION; FUNGAL GENE; GENE EXPRESSION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IN VITRO STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MULTIPLE MYELOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; OROPHARYNX;

ANTIFUNGAL AGENTS; CANDIDA GLABRATA; CANDIDIASIS; CARRIER STATE; CHEMOPREVENTION; DNA FINGERPRINTING; DNA, FUNGAL; DRUG RESISTANCE, FUNGAL; ECHINOCANDINS; FLUCONAZOLE; GENOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; MYCOLOGICAL TYPING TECHNIQUES; OROPHARYNX; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE;

CANDIDA GLABRATA;

EID: 77950587176     PISSN: 13693786     EISSN: 14602709     Source Type: Journal    
DOI: 10.3109/13693780903213504     Document Type: Article

References (9)

1. Fidel PL, Jr . Vazquez JA, Sobel JD. Candida glabrata : review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans . Clin Microbiol Rev 1999; 12: 80-96 .
2. Pfaller MA, Diekema DJ, Gibbs DL, et al. Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fl uconazole and voriconazole determined by CLSI standardized disk diffusion testing. J Clin Microbiol 2007; 45: 1735-1745 .
3. Patterson TF, Kirkpatrick WR, Revankar SG, et al. Comparative evaluation of macrodilution and chromogenic agar screening for determining fl uconazole susceptibility of Candida albicans . J Clin Microbiol 1996; 34: 3237-3239 .
4. Patterson TF, Revankar SG, Kirkpatrick WR, et al . Simple method for detecting fl uconazole-resistant yeasts with chromogenic agar. J Clin Microbiol 1996; 34: 1794-1797 .
5. CLSI. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts; Approved Standard - 3rd edn . CLSI document M27-A3 . Wayne PA : Clinical and Laboratory Standards Institute ; 2008.
6. Bautista-Munoz C, Boldo XM, Villa-Tanaca L, Hernandez-Rodriguez C. Identifi cation of Candida spp. by randomly amplifi ed polymorphic DNA analysis and differentiation between Candida albicans and Candida dubliniensis by direct PCR methods. J Clin Microbiol 2003; 41: 414-420 .
7. Becker K, Badehorn D, Deiwick S, Peters G, Fegeler W. Molecular genotyping of Candida species with special respect to Candida ( Torulopsis ) glabrata strains by arbitrarily primed PCR. J Med Microbiol 2000; 49: 575-581 .
8. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408 .
9. Tsai HF, Krol AA, Sarti KE, Bennett JE. Candida glabrata PDR1, a transcriptional regulator of a pleiotropic drug resistance network, mediates azole resistance in clinical isolates and petite mutants. Antimicrob Agents Chemother 2006; 50: 1384-1392 .